Clinical Trials
Publications
Careers
Contact Us

About INOVIO
DNA Medicines Technology
DNA Medicines Pipeline
Investors & Media
Clinical Trials
Publications
Careers
Contact Us

NEWS ALERT

FDA Accepts for Review INOVIO’s BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)

About INOVIO
DNA Medicines Technology
DNA Medicines Pipeline
Investors & Media
Clinical Trials
Publications
Careers
Contact Us

Purpose, Mission and Values
Leadership
Partnerships

CEO CORNER

Dr. J. Joseph Kim

J. Joseph Kim, Ph.D.
President, Chief Executive Officer, Director

CEO CORNER

Dr. J. Joseph Kim

J. Joseph Kim, Ph.D.
President, Chief Executive Officer, Director

xxx

DMAbs for Prevention of COVID-19

SUBSCRIBE FOR UPDATES FROM INOVIO
Register to receive email alerts for INOVIO press releases

About Inovio
DNA Medicines Technology
DNA Medicines Pipeline
Investors & Media
For Patients
Publications
Careers
Contact Us

Safe Harbor Statement
Expanded Access
Privacy Policy
Terms & Conditions

© Copyright 2026 INOVIO Pharmaceuticals. All rights reserved.